Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2010 - 2026)

Ionis Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.17 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 29.28% year-over-year to 0.17 in Q1 2026; TTM through Mar 2026 was 0.17, a 29.28% decrease from a year earlier, with the FY2025 full-year figure at 0.29, up 22.89% from the prior year.
• Asset Utilization Ratio rose to 0.17 in Q1 2026 per IONS's latest filing, from 0.15 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.36 in Q3 2022 and bottomed at 0.15 in Q4 2025.
• The 5-year median for Asset Utilization Ratio is 0.24 (2022), against an average of 0.24.
• Across the five-year window, Asset Utilization Ratio soared 133.23% in 2022 and slumped 42.86% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.24 in 2022, then rose by 12.18% to 0.27 in 2023, then fell by 12.84% to 0.23 in 2024, then tumbled by 35.03% to 0.15 in 2025, then grew by 15.83% to 0.17 in 2026.
• Per Business Quant, the three latest IONS Asset Utilization Ratio figures stand at 0.17 (Q1 2026), 0.15 (Q4 2025), and 0.17 (Q3 2025).